Vaccine

SwineCast 0975, WPX - NPPC Thursday Press Briefing on Trade, Vaccine Bank, and Economics

SwineCast 0975 Show Notes:

Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porcine Reproductive & Respiratory Syndrome (PRRSV)


Pathogenesis and control of Chinese highly pathogenic Porcine Reproductive & Respiratory Syndrome (PRRSV) - Dr. Hanchun Yang, China Agricultural University, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.

Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) vaccination on infectious load and implications


Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) vaccination on infectious load and implications for area control and eradication - Dr. Mike Roof, Boehringer Ingelheim, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.

Dr. Tanja Opriessnig - Update on novel experimental pig vaccine approaches


Update on novel experimental pig vaccine approaches - Dr. Tanja Opriessnig, The Roslin Institute, University of Edinburgh and Iowa State University, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.

Dr. Roger Main - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) vaccination on infectious load and implications


Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) vaccination on infectious load and implications for area control and eradication - Dr. Roger Main, Iowa State University, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.

SwineCast 0932, Elanco's New Vaccine Innovation Center Looks To The Future

SwineCast 0932 Show Notes:
  • John Blue talks with Aaron Schacht, Vice President of Elanco’s Global Research and Development about the challenges of innovation, location and Elanco's focus on world food needs by 2050.

SwineCast 0931, ATM - Maximize Value Through Good Gilt Introduction Protocols

SwineCast 0931 Show Notes:

SwineCast 0927, Aptimmune Offering New Vaccination Technology

SwineCast 0927 Show Notes:
  • Aptimmune Biologics is bringing new intra-nasal vaccination technology to the swine industry.  CEO Aaron Gilbertie discusses the company's focus and products at World Pork Expo.

Using Complexity Theory To Understand Swine Vaccine Responses

 The Importance of Tissue-Level ActivityThe Chaos of Vaccine Responses: The Importance of Tissue-Level Activity Dr. David Hurley, Department of Large Animal Medicine, University of Georgia, dives into the science and physiology of tissue level activity and using Chaos Theory (or Complexity Theory if you prefer) to understand vaccine responses. This presentation shares detailed illustrations that explain tissue level events (their duration and strength plus their diversity).

One key takeaway is vaccines are able to protect target tissues other than the vaccine site because once ordered and produced in effective quantity and for the right challenge, the products will enter all body tissues expressing damage and danger. [video].

Dr. Jeff Galvin - Utilization of Modern Scientific Technologies to Produce Compatible Antigens for Swine Vaccines


Utilization of Modern Scientific Technologies to Produce Compatible Antigens for Swine Vaccines - Dr. Jeff Galvin, Zoetis, from the 2015 North American PRRS Symposium, December 4 - 5, 2015, Chicago, IL, USA.

Syndicate content